2BB score and signals
Ovid Therapeutics Inc.’s current 2BB score is 37 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 43 | Moderate |
| Momentum | 61 | Improving |
| Financial strength | 30 | Weak |
| Quality | 35 | Weak |
| Risk | 43 | Moderate |
Company facts
| Founded | 2014 |
| Employees | 23 |
| 52-week range | $1.18 – $3.10 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-16 | — | -0.0959 | — | $89,188.00 |
| 2026-11-10 | — | -0.0898 | — | $15,871.00 |
| 2026-08-18 | — | -0.1173 | — | $0.00 |
| 2026-05-12 | -0.12 | -0.1227 | $0.00 | $33,150.00 |
Related companies
